Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study.
paper
Cited
Public
Unavailable
- Authors
- Blanco, Carlos; Hasin, Deborah S; Wall, Melanie M; FlΓ³rez-Salamanca, Ludwing; Hoertel, Nicolas; Wang, Shuai; Kerridge, Bradley T; Olfson, Mark
- Year
- 2016
- Journal
- JAMA psychiatry
- PMID
- 26886046
- DOI
- 10.1001/jamapsychiatry.2015.3229
IMPORTANCE: With rising rates of marijuana use in the general population and an increasing number of states legalizing recreational marijuana use and authorizing medical marijuana programs, there are renewed clinical and policy concerns regarding the mental health effects of cannabis use. OBJECTIVE: To examine prospective associations between cannabis use and risk of mental health and substance use disorders in the general adult population. DESIGN, SETTING, AND PARTICIPANTS: A nationally representative sample of US adults aged 18 years or older was interviewed 3 years apart in the National Epidemiologic Survey on Alcohol and Related Conditions (wave 1, 2001-2002; wave 2, 2004-2005). The primary analyses were limited to 34β―653 respondents who were interviewed in both waves. Data analysis was conducted from March 15 to November 30, 2015. MAIN OUTCOMES AND MEASURES: We used multiple regression and propensity score matching to estimate the strength of independent associations between cannabis use at wave 1 and incident and prevalent psychiatric disorders at wave 2. Psychiatric disorders were measured with a structured interview (Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV). In both analyses, the same set of wave 1 confounders was used, including sociodemographic characteristics, family history of substance use disorder, disturbed family environment, childhood parental loss, low self-esteem, social deviance, education, recent trauma, past and present psychiatric disorders, and respondent's history of divorce. RESULTS: In the multiple regression analysis of 34β―653 respondents (14β―564 male [47.9% weighted]; mean [SD] age, 45.1 [17.3] years), cannabis use in wave 1 (2001-2002), which was reported by 1279 respondents, was significantly associated with substance use disorders in wave 2 (2004-2005) (any substance use disorder: odds ratio [OR], 6.2; 95% CI, 4.1-9.4; any alcohol use disorder: OR, 2.7; 95% CI, 1.9-3.8; any cannabis use disorder: OR, 9.5; 95% CI, 6.4-14.1; any other drug use disorder: OR, 2.6; 95% CI, 1.6-4.4; and nicotine dependence: OR, 1.7; 95% CI, 1.2-2.4), but not any mood disorder (OR, 1.1; 95% CI, 0.8-1.4) or anxiety disorder (OR, 0.9; 95% CI, 0.7-1.1). The same general pattern of results was observed in the multiple regression analyses of wave 2 prevalent psychiatric disorders and in the propensity score-matched analysis of incident and prevalent psychiatric disorders. CONCLUSIONS AND RELEVANCE: Within the general population, cannabis use is associated with an increased risk for several substance use disorders. Physicians and policy makers should take these associations of cannabis use under careful consideration.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | 2023 | 37626487 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Acute Effects of Cannabis on Alcohol Craving and Consumption: A Randomized Controlled Crossover Trial. | Metrik J et al. | β | 2026 | β |
| Cannabis Use in a Community-Based Sample of Adults Diagnosed With ADHD: Prevalence, Impact on Symptoms, and Stimulant Side Effects. | Ryan JE et al. | β | 2026 | β |
| Emerging Adults Seeking Treatment for Their Eating Disorder: An Empirical Look at Young Adults Relative to Adults Over 25. | Laliberte MM et al. | β | 2026 | β |
| Insights Into Cannabis and Cannabinoids: Chemical Properties, Legal Perspectives, and Therapeutic Applications. | Vihal S et al. | β | 2026 | β |
| Letter to the Editor Regarding "the Association Between Preoperative Cannabis Use and Anxiety, Pain Scores and Opioid Consumption in Patients Undergoing Spinal Fusion: A Retrospective Cohort Study". | Veerasatian T et al. | β | 2026 | β |
| An Analysis of 16-Year Trends in Cannabis Use Disorder Treatment: Predictors, Barriers, and Utilization Patterns. | Graves BD et al. | β | 2025 | β |
| Assessing anxiety longitudinally among medical cannabis patients in Pennsylvania. | Ataiants J et al. | β | 2025 | β |
| A user-informed perspective of the toxicological data gap in India's cannabis landscape. | Riyaz M | β | 2025 | β |
| Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks. | Johnson BW et al. | β | 2025 | β |
| Cannabis administration is associated with reduced alcohol consumption: Evidence from a novel laboratory co-administration paradigm. | Pince CL et al. | β | 2025 | β |
| Cannabis retail store density and county-level mortality from injury in the state of Washington from 2009-2020. | Kerr WC et al. | β | 2025 | β |
| Cannabis Use and Sexual Identity Exploration in Emerging Adulthood: A Call for Inclusive, Trauma-Informed Campus Mental Health Strategies. | Paul FA et al. | β | 2025 | β |
| Cannabis use is associated with changes in psychological and functional well-being during young adulthood: evidence from self-reports and hair analyses. | Johnson-Ferguson L et al. | β | 2025 | β |
| Central Executive Network drives delta-9-tetrahydrocannabinol (THC)-induced nonlinear changes in large-scale functional connectivity in adolescent nonhuman primates. | Byun AJS et al. | β | 2025 | β |
| Chronic cannabis use is associated with alterations in resting-state cerebellar-cortical connectivity. | Salsano I et al. | β | 2025 | β |
| Effects of Cannabis Exposure on Adolescent Health and Development: A Narrative Review. | Li R et al. | β | 2025 | β |
| Heavy and Chronic Cannabis Addiction does not Impact Motor Function: A BOLD-fMRI Study. | Boujraf S et al. | β | 2025 | β |
| Hippocampal apoptosis: Molecular mechanisms triggered by toxic cannabinoid exposure: A narrative review. | Mashayekhi-Sardoo H et al. | β | 2025 | β |
| Identification and External Validation of a Problem Cannabis Risk Network. | Lichenstein SD et al. | β | 2025 | β |
| Labeling of Cannabis Products From Licensed and Unlicensed Retailers in New York. | Becker TD et al. | β | 2025 | β |
| Managing substance abuse on psychiatric units: a scoping review. | Hudon A et al. | β | 2025 | β |
| Medicinal Cannabis and Consumer Vulnerability in Australia: A Nexus of Policy and Market Factors. | Gething K et al. | β | 2025 | β |
| Medicinal cannabis: is current use clinically justified? | Scott RJ et al. | β | 2025 | β |
| Nicotine dependence and incident psychiatric disorders: prospective evidence from US national study. | Airagnes G et al. | β | 2025 | β |
| Patterns of past month cannabis consumption and cannabis use disorder - Insights from a nationally representative survey. | Kritikos AF et al. | β | 2025 | β |
| Prevalence of Cannabis Use Disorder Among Primary Care Patients with Varying Frequency of Past-Year Cannabis Use. | Lapham GT et al. | β | 2025 | β |
| The association between cannabis and depression: an updated Systematic Review and Meta-analysis. | Churchill V et al. | β | 2025 | β |
| The Association Between Preoperative Cannabis Use and Anxiety, Pain Scores and Opioid Consumption in Patients Undergoing Spinal Fusion: A Retrospective Cohort Study. | Amoroso K et al. | β | 2025 | β |
| The endocannabinoid and paracannabinoid systems in natural reward processes: possible pharmacological targets? | Friuli M et al. | β | 2025 | β |
| The social-structural contexts of cannabis consumption and harm reduction among young Nigerian women. | Nelson EU et al. | β | 2025 | β |
| A national study of clinical discussions about cannabis use among Veteran patients prescribed opioids. | Zaman T et al. | β | 2024 | β |
| Association between illegal drug use and cigarette smoking among Ethiopian students: A systematic review and meta-analysis. | Daba C et al. | β | 2024 | β |
| Cannabis use and binge eating: Examining the relationship between cannabis use and clinical severity among adults with binge eating. | Wilkinson ML et al. | β | 2024 | β |
| Cannabis use and social anxiety disorder in emerging adulthood: Results from a nationally representative sample. | Single A et al. | β | 2024 | β |
| Effects of Recreational Cannabis Legalization on Mental Health: Scoping Review. | Fortier A et al. | β | 2024 | β |
| Medical cannabis: From research breakthroughs to shifting public perceptions and ensuring safe use. | Hossain MK et al. | β | 2024 | β |
| Review of the Use of Medicinal Cannabis Products in Palliative Care. | Troyer J et al. | β | 2024 | β |
| A cross-national study on adolescent substance use: Intentions, peer substance use, and parent-adolescent communication. | Defoe IN et al. | β | 2023 | β |
| Anxiety sensitivity and cigarette use on cannabis use problems, perceived barriers for cannabis cessation, and self-efficacy for quitting among adults with cannabis use disorder. | Orr MF et al. | β | 2023 | β |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | β | 2023 | β |
| Cannabis craving in response to alcohol cues among adolescents and young adults in the laboratory and in daily life. | Wycoff AM et al. | β | 2023 | β |
| Cannabis-related problems and social anxiety: The roles of sex and cannabis use motives updated. | Morris PE et al. | β | 2023 | β |
| Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies. | Xiao KB et al. | β | 2023 | β |
| Cannabis Use Associations with Adverse Psychosocial Functioning among North American College Students. | Vidal C et al. | β | 2023 | β |
| Cannabis use breaks in young adults: The highs and lows of tolerance breaks. | Ansell EB et al. | β | 2023 | β |
| Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder. | Jefsen OH et al. | β | 2023 | β |
| Cannabis use in repeated representative cross-sectional studies on Italian adults after the COVID-19 pandemic. | Amerio A et al. | β | 2023 | β |
| Fatty Acid Amide Hydrolase: An Integrative Clinical Perspective. | Santoso AD et al. | β | 2023 | β |
| Genome-wide DNA methylation association study of recent and cumulative marijuana use in middle aged adults. | Nannini DR et al. | β | 2023 | β |
| Perceptions of Safety of Daily Cannabis vs Tobacco Smoking and Secondhand Smoke Exposure, 2017-2021. | Chambers J et al. | β | 2023 | β |
| Peripheral signature of altered synaptic integrity in young onset cannabis use disorder: A proteomic study of circulating extracellular vesicles. | Ganesh S et al. | β | 2023 | β |
| Prevalence and association of non-medical cannabis use with post-procedural healthcare utilisation in patients undergoing surgery or interventional procedures: a retrospective cohort study. | Ahrens E et al. | β | 2023 | β |
| Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns. | Samuel S et al. | β | 2023 | β |
| Substance use trajectories among emerging adult Black men: Risk factors and consequences. | Kwon E et al. | β | 2023 | β |
| The long-term effects of adolescent Ξ9-tetrahydrocannabinol on brain structure and function assessed through neuroimaging techniques in male and female rats. | Orihuel J et al. | β | 2023 | β |
| The role of personality traits on self-medicated cannabis in rheumatoid arthritis patients: A multivariable analysis. | Galindo-Donaire JR et al. | β | 2023 | β |
| The role of sex in daily levels of high-risk alcohol and cannabis co-use. | McManus K et al. | β | 2023 | β |
| Towards a New Dynamic Interaction Model of Adolescent CUD Manifestation, Prevention, and Treatment: A Narrative Review. | Oosten W et al. | β | 2023 | β |
| Unhealthy behaviors associated with mental health disorders: a systematic comparative review of diet quality, sedentary behavior, and cannabis and tobacco use. | Johnstad PG | β | 2023 | β |
| Which factors are associated with cannabis use among adolescents in Andalusia? An application of the I-Change model. | TorrejΓ³n-Guirado MC et al. | β | 2023 | β |
| 3-Year Follow-up of Lower Risk Cannabis Use Patterns: Evidence from a Longitudinal Survey. | Chen T et al. | β | 2022 | β |
| Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence. | Kuhns L et al. | β | 2022 | β |
| Associations between modes of cannabis use in daily life with concurrent and longitudinal hazardous use and consequences. | Bedillion MF et al. | β | 2022 | β |
| Associations of Current and Remitted Cannabis Use Disorder With Health-related Quality of Life and Employment Among US Adults. | Rhee TG et al. | β | 2022 | β |
| Attitudes and Beliefs Toward Cannabis Before Recreational Legalization: A Cross-Sectional Study of Community Adults in Ontario. | Turna J et al. | β | 2022 | β |
| Atypical working hours are associated with tobacco, cannabis and alcohol use: longitudinal analyses from the CONSTANCES cohort. | Hamieh N et al. | β | 2022 | β |
| Autism and associated disorders: cannabis as a potential therapy. | Babayeva M et al. | β | 2022 | β |
| Cannabis and alcohol co-use: The effects of intensity of cannabis use among heavy drinkers. | Venegas A et al. | β | 2022 | β |
| Cannabis Use Disorder: A Behavioral Economic Perspective. | Aston ER et al. | β | 2022 | β |
| Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study. | Quick CR et al. | β | 2022 | β |
| Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients. | Lapham GT et al. | β | 2022 | β |
| Expanding Current Approaches to Solve the Opioid Crisis. | Blanco C et al. | β | 2022 | β |
| Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review. | Prieto-Arenas L et al. | β | 2022 | β |
| Genetic correlation, pleiotropy, and causal associations between substance use and psychiatric disorder. | Jang SK et al. | β | 2022 | β |
| Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder. | Livingston NA et al. | β | 2022 | β |
| Patterns of Cannabis and Alcohol Co-Use: Substitution Versus Complementary Effects. | Gunn RL et al. | β | 2022 | β |
| Physical exertion at work and addictive behaviors: tobacco, cannabis, alcohol, sugar and fat consumption: longitudinal analyses in the CONSTANCES cohort. | Hamieh N et al. | β | 2022 | β |
| Prevalence of anxiety and depression among engineering students consuming cannabis. | Vaziri-Harami R et al. | β | 2022 | β |
| Public Health Implications of Cannabis Legalization: An Exploration of Adolescent Use and Evidence-Based Interventions. | Donnelly J et al. | β | 2022 | β |
| Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids. | Jabalameli MR et al. | β | 2022 | β |
| Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study. | Zongo A et al. | β | 2022 | β |
| Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants. | Lichenstein SD et al. | β | 2022 | β |
| Trends and characteristics of cannabis-associated emergency department visits in the United States, 2006-2018. | Roehler DR et al. | β | 2022 | β |
| Unmet Need in Relation to Mental Healthcare and Past-Month Drug Use among People with Mental Illness in the United States. | Reid BE et al. | β | 2022 | β |
| Upregulation of Uric Acid Production and Caspase 3 Signalling Mediates Rohypnol-Induced Cardiorenal Damage. | Akhigbe RE et al. | β | 2022 | β |
| Adolescent cannabis and tobacco use are associated with opioid use in young adulthood-12-year longitudinal study in an urban cohort. | Thrul J et al. | β | 2021 | β |
| Alcohol trajectories and subsequent risk for opioid misuse in a cohort of urban adolescents. | Thrul J et al. | β | 2021 | β |
| Bipolar disorder and cannabis use: A bidirectional two-sample Mendelian randomization study. | Jefsen OH et al. | β | 2021 | β |
| Cannabis and cannabidiol use among autistic and non-autistic adults in the UK: a propensity score-matched analysis. | Hua DY et al. | β | 2021 | β |
| Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease. | Bogale K et al. | β | 2021 | β |
| Cannabis use outcomes by past-month binge drinking status in the general United States population. | Vijapur SM et al. | β | 2021 | β |
| Comparing older nonmedical and medical cannabis users: health-related characteristics, cannabis use patterns, and cannabis sources. | Choi NG et al. | β | 2021 | β |
| Concurrent E-cigarette and marijuana use and health-risk behaviors among U.S. high school students. | Jacobs W et al. | β | 2021 | β |
| Coping mechanisms used by the families of mental health care users in Mahikeng sub-district, North West province. | Modise TP et al. | β | 2021 | β |
| Demographic risk factors for co-occurring suicidality and cannabis use disorders: Findings from a nationally representative United States sample. | Kelly LM et al. | β | 2021 | β |
| Effect of alcohol, tobacco, and cannabis co-use on gray matter volume in heavy drinkers. | Grodin EN et al. | β | 2021 | β |
| Endocannabinoids, cannabinoids and the regulation of anxiety. | Petrie GN et al. | β | 2021 | β |
| Financial Strain, Mental Illness, and Homelessness: Results From a National Longitudinal Study. | Elbogen EB et al. | β | 2021 | β |
| Frequent teenage cannabis use: Prevalence across adolescence and associations with young adult psychopathology and functional well-being in an urban cohort. | Shanahan L et al. | β | 2021 | β |
| Gender discrimination and illicit drug use among African American and European American adolescents and emerging adults. | Ahuja M et al. | β | 2021 | β |
| How High? Trends in Cannabis Use Prior to First Admission to Inpatient Psychiatry in Ontario, Canada, between 2007 and 2017. | McGuckin T et al. | β | 2021 | β |
| Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping. | al'Absi M et al. | β | 2021 | β |
| Marijuana Use and Sexual Risk Behavior Among Young Black Men Who Have Sex with Men in California. | D'Anna LH et al. | β | 2021 | β |
| Medication overuse headache in patients with chronic migraine using cannabis: A case-referent study. | Zhang N et al. | β | 2021 | β |
| Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview. | Kumar P et al. | β | 2021 | β |
| Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study. | Fond G et al. | β | 2021 | β |
| Prevalence and correlates of daily blunt use among U.S. African American, Hispanic, and White adults from 2014 to 2018. | Mantey DS et al. | β | 2021 | β |
| Prevalence and predictors of work-related depression, anxiety, and stress among waiters: A cross-sectional study in upscale restaurants. | Saah FI et al. | β | 2021 | β |
| Sex-dependent effects of alcohol administration on the urge to use cannabis. | Venegas A et al. | β | 2021 | β |
| The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review. | Sorkhou M et al. | β | 2021 | β |
| The Future of Substance Abuse Now: Relationships among Adolescent Use of Vaping Devices, Marijuana, and Synthetic Cannabinoids. | Tai H et al. | β | 2021 | β |
| Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders. | Ahmed I et al. | β | 2021 | β |
| Accuracy of Medical Marijuana Claims Made by Popular Websites. | Boatwright KD et al. | β | 2020 | β |
| Association of illicit drug use in adolescence with socioeconomic and criminal justice outcomes in adulthood: prospective findings from a UK national birth cohort. | White J et al. | β | 2020 | β |
| Association of Marijuana, Mental Health, and Tobacco in Colorado. | Stewart SB et al. | β | 2020 | β |
| Associations between Psychiatric Disorders and Cannabis-Related Disorders Documented in Electronic Health Records. | Campbell A et al. | β | 2020 | β |
| Associations of cigarette smoking with psychiatric disorders: evidence from a two-sample Mendelian randomization study. | Yuan S et al. | β | 2020 | β |
| A Web-Based Program for Cannabis Use and Psychotic Experiences in Young People (Keep It Real): Protocol for a Randomized Controlled Trial. | Hides L et al. | β | 2020 | β |
| Brain structural changes in cannabis dependence: association with MAGL. | Manza P et al. | β | 2020 | β |
| Cannabinoids as therapeutics for PTSD. | Sbarski B et al. | β | 2020 | β |
| Cannabis use and the sperm epigenome: a budding concern? | Schrott R et al. | β | 2020 | β |
| Cannabis Use as a Risk Factor for Depression, Anxiety, and Suicidality: Epidemiological Associations and Implications for Nurses. | Halladay JE et al. | β | 2020 | β |
| Cannabis use, depression and self-harm: phenotypic and genetic relationships. | Hodgson K et al. | β | 2020 | β |
| Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants. | Rognli EB et al. | β | 2020 | β |
| Cannabis use, problem-gambling severity, and psychiatric disorders: Data from the National Epidemiological Survey on Alcohol and Related Conditions. | Hammond CJ et al. | β | 2020 | β |
| Cannabis use, subsequent other illicit drug use and drug use disorders: A 16-year follow-up study among Swedish adults. | Rabiee R et al. | β | 2020 | β |
| Characterizing symptoms of cannabis use disorder in a sample of college students. | Pellegrino AJ et al. | β | 2020 | β |
| Commentary on Chan & Hall (2020): Advances in specifying cannabis consumption. | Compton WM et al. | β | 2020 | β |
| Deconstructing the neurobiology of cannabis use disorder. | Ferland JN et al. | β | 2020 | β |
| Does cannabis use increase anxiety disorders? A literature review. | Shalit N et al. | β | 2020 | β |
| Frequency of cannabis use and alcohol-associated adverse effects in a representative sample of U.S. adolescents and youth (2002-2014) a cross-sectional study. | Ramadan MM et al. | β | 2020 | β |
| Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study. | De Aquino JP et al. | β | 2020 | β |
| Inclusion of Cannabis Users in Alcohol Research Samples: Screening In, Screening Out, and Implications. | Venegas A et al. | β | 2020 | β |
| Is there a relationship between cannabis use problems, emotion dysregulation, and mental health problems among adults with chronic pain? | Orr MF et al. | β | 2020 | β |
| Longitudinal associations between negative urgency, symptoms of depression, cannabis and alcohol use in veterans. | Gunn RL et al. | β | 2020 | β |
| Marijuana Use and Potential Implications of Marijuana Legalization. | Grigsby TM et al. | β | 2020 | β |
| Medical cannabis use among individuals with cancer: An unresolved and timely issue. | Nugent SM et al. | β | 2020 | β |
| Opioid use disorders and hospital palliative care among patients with gastrointestinal cancers: Ten-year trend and associated factors in the U.S. from 2005 to 2014. | Hwang J et al. | β | 2020 | β |
| Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review. | Kondo KK et al. | β | 2020 | β |
| Prescribing medical cannabis: ethical considerations for primary care providers. | Glickman A et al. | β | 2020 | β |
| Recreational drug use among Nigerian university students: Prevalence, correlates and frequency of use. | Ajayi AI et al. | β | 2020 | β |
| Reduced Segregation Between Cognitive and Emotional Processes in Cannabis Dependence. | Manza P et al. | β | 2020 | β |
| 'Standard THC units': a proposal to standardize dose across all cannabis products and methods of administration. | Freeman TP et al. | β | 2020 | β |
| The Intersection between Spliff Usage, Tobacco Smoking, and Having the First Joint after Waking. | Kumar N et al. | β | 2020 | β |
| Understanding motivations for large US cannabis firms' participation in the cannabis space: Qualitative study exploring views of key decision-makers. | Kumar N et al. | β | 2020 | β |
| US Trends of Opioid-use Disorders and Associated Factors Among Hospitalized Patients With Spinal Conditions and Treatment From 2005 to 2014. | Lee SW et al. | β | 2020 | β |
| What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis. | Leung J et al. | β | 2020 | β |
| Why do patients come to the emergency department after using cannabis? | Shelton SK et al. | β | 2020 | β |
| A case study for the use of medical cannabis in generalized anxiety disorder. | Walkaden C | β | 2019 | β |
| Adolescent Ξ<sup>9</sup>-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-ΞΊB-Cyclooxygenase-2 Signaling to ImpairΒ Memory in Adulthood. | Jouroukhin Y et al. | β | 2019 | β |
| An Examination of Comorbid Psychiatric Disorders in Disordered Gamblers Versus Other Substance-Related Disorders. | Nicholson R et al. | β | 2019 | β |
| Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men. | Okafor CN et al. | β | 2019 | β |
| Associations between young adult marijuana outcomes and availability of medical marijuana dispensaries and storefront signage. | Shih RA et al. | β | 2019 | β |
| Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes. | Alhamad T et al. | β | 2019 | β |
| Cannabis use, depression and self-harm: phenotypic and genetic relationships | Hodgson K et al. | β | 2019 | β |
| Cannabis use during methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis. | McBrien H et al. | β | 2019 | β |
| Childhood Protective Factors and a Prevention Program Reduce Later Problem Behaviors. | Duncan RJ et al. | β | 2019 | β |
| Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. | Agarwal R et al. | β | 2019 | β |
| Does cannabis legalisation change healthcare utilisation? A population-based study using the healthcare cost and utilisation project in Colorado, USA. | Delling FN et al. | β | 2019 | β |
| Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective. | Archie SR et al. | β | 2019 | β |
| Implementing social justice in the transition from illicit to legal cannabis. | Adinoff B et al. | β | 2019 | β |
| Perceived health, medical, and psychiatric conditions in individual and dual-use of marijuana and nonprescription opioids. | Frohe T et al. | β | 2019 | β |
| Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review | Kondo K et al. | β | 2019 | β |
| Positive and Negative Effects of Cannabis and Cannabinoids on Health. | Cohen K et al. | β | 2019 | β |
| Priming primary care providers to engage in evidence-based discussions about cannabis with patients. | Kansagara D et al. | β | 2019 | β |
| Risks Associated with Mid level Cannabis Use Among People Treated for Alcohol Use Disorder. | Subbaraman MS et al. | β | 2019 | β |
| Shared and specific associations of substance use disorders on adverse outcomes: A national prospective study. | Franco S et al. | β | 2019 | β |
| The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment. | Shams I et al. | β | 2019 | β |
| The Effects of Marijuana Use on Transitions through Stages of Alcohol Involvement for Men and Women in the NESARC I and II. | Green KM et al. | β | 2019 | β |
| The University of Vermont Wellness Environment: Feasibility and Initial Results of a College Undergraduate Health-Promoting Program. | Bai Y et al. | β | 2019 | β |
| Trends and associated factors of use of opioid, heroin, and cannabis among patients for emergency department visits in Nevada: 2009-2017. | Kim PC et al. | β | 2019 | β |
| Trends and Related Factors of Cannabis-Associated Emergency Department Visits in the United States: 2006-2014. | Shen JJ et al. | β | 2019 | β |
| Affect and cannabis use in daily life: a review and recommendations for future research. | Wycoff AM et al. | β | 2018 | β |
| Age Differences in Daily and Nondaily Cannabis Use in the United States, 2002-2014. | Mauro PM et al. | β | 2018 | β |
| A longitudinal study of reciprocal risk between mental and substance use disorders among Mexican youth. | Borges G et al. | β | 2018 | β |
| Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer. | Zhang H et al. | β | 2018 | β |
| Cannabis for Chronic Pain: Challenges and Considerations. | Romero-Sandoval EA et al. | β | 2018 | β |
| Cannabis regulatory science: risk-benefit considerations for mental disorders. | Borodovsky JT et al. | β | 2018 | β |
| Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States. | Olfson M et al. | β | 2018 | β |
| Cannabis use during alcohol treatment is associated with alcohol-related problems one-year post-treatment. | Subbaraman MS et al. | β | 2018 | β |
| Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders. | Reeves LE et al. | β | 2018 | β |
| Comparison of the locations where young adults smoke, vape, and eat/drink cannabis: Implications for harm reduction. | Jones CB et al. | β | 2018 | β |
| Comprehensive interventions for reducing cannabis use. | Tirado-MuΓ±oz J et al. | β | 2018 | β |
| Contribution of alcohol and drug co-use to substance use problems: Data from a nationally-representative sample of U.S. adults who have never been to treatment. | Karriker-Jaffe KJ et al. | β | 2018 | β |
| Daily Patterns of Marijuana and Alcohol Co-Use Among Individuals with Alcohol and Cannabis Use Disorders. | Metrik J et al. | β | 2018 | β |
| Drug use among youth: National survey data support a common liability of all drug use. | DuPont RL et al. | β | 2018 | β |
| DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles. | Kerridge BT et al. | β | 2018 | β |
| Gender-specific association of functional <i>prodynorphin</i> 68 bp repeats with cannabis exposure in an African American cohort. | Yuferov V et al. | β | 2018 | β |
| Is Cannabis Use Associated With Increased Risk of Cigarette Smoking Initiation, Persistence, and Relapse? Longitudinal Data From a Representative Sample of US Adults. | Weinberger AH et al. | β | 2018 | β |
| Job exposure to the public in relation with alcohol, tobacco and cannabis use: Findings from the CONSTANCES cohort study. | Airagnes G et al. | β | 2018 | β |
| Marijuana buyers in the United States, 2010-2014. | Azofeifa A et al. | β | 2018 | β |
| Marijuana Use Among Adults 50 Years or Older in the 21st Century. | Lloyd SL et al. | β | 2018 | β |
| Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis. | Sarvet AL et al. | β | 2018 | β |
| Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis. | Butelman ER et al. | β | 2018 | β |
| Overlaps in pharmacology for the treatment of chronic pain and mental health disorders. | Sutherland AM et al. | β | 2018 | β |
| Perceived barriers for cannabis cessation: Relations to cannabis use problems, withdrawal symptoms, and self-efficacy for quitting. | Zvolensky MJ et al. | β | 2018 | β |
| Policy Reform with Marijuana Use: Weighing Risks and Benefits. | Nkemdirim Okere A | β | 2018 | β |
| Prevalence of Behavioral Health Conditions Across Frequency of Cannabis Use Among Adult Primary Care Patients in Washington State. | Lapham GT et al. | β | 2018 | β |
| Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States. | Desai R et al. | β | 2018 | β |
| Recent cannabis use among Veterans in the United States: Results from a national sample. | Davis AK et al. | β | 2018 | β |
| Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults. | Keyhani S et al. | β | 2018 | β |
| The Psychiatric Consequences of Cannabinoids. | De Aquino JP et al. | β | 2018 | β |
| Use of Psychotropic Medications and Illegal Drugs, and Related Consequences Among French Pharmacy Students - SCEP Study: A Nationwide Cross-Sectional Study. | Balayssac D et al. | β | 2018 | β |
| US Epidemiology of Cannabis Use and Associated Problems. | Hasin DS | β | 2018 | β |
| Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences. | Zielinski L et al. | β | 2017 | β |
| Association of cannabis use with the development of elevated anxiety symptoms in the general population: a meta-analysis. | Twomey CD | β | 2017 | β |
| Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity? | Butelman ER et al. | β | 2017 | β |
| Cannabinoid Hyperemesis Syndrome (CHS): A Parisian Case Series. | Marillier M et al. | β | 2017 | β |
| Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? | Maccarrone M et al. | β | 2017 | β |
| Clarifying the link between cannabis use and risk for psychosis. | Weiss SRB et al. | β | 2017 | β |
| Commentary: Navigating the complexities of marijuana. | Weiss SRB et al. | β | 2017 | β |
| Differences in behavioral health disorders and unmet treatment needs between medical marijuana users and recreational marijuana users: Results from a national adult sample. | Park JY et al. | β | 2017 | β |
| Frequency of Cannabis Use Among Primary Care Patients in Washington State. | Lapham GT et al. | β | 2017 | β |
| Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive-Behavioral Treatment for PTSD and Substance Use Disorders. | Ruglass LM et al. | β | 2017 | β |
| Longitudinal Studies on the Etiology of Cannabis Use Disorder: A Review. | Courtney KE et al. | β | 2017 | β |
| Long lasting effects of chronic heavy cannabis abuse. | Nestoros JN et al. | β | 2017 | β |
| Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. | Steenkamp MM et al. | β | 2017 | β |
| Marijuana Use and Organ Transplantation: a Review and Implications for Clinical Practice. | Rai HS et al. | β | 2017 | β |
| Marijuana use disorder symptoms among recent onset marijuana users. | Dierker L et al. | β | 2017 | β |
| Medical Marijuana and the Treatment of Post Traumatic Stress Disorder: A Survey of Michigan Psychiatrists' Opinions. | Custodia J et al. | β | 2017 | β |
| Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. | Bridgeman MB et al. | β | 2017 | β |
| Older adults who use or have used marijuana: Help-seeking for marijuana and other substance use problems. | Choi NG et al. | β | 2017 | β |
| Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders. | Skalisky J et al. | β | 2017 | β |
| Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States. | Wu LT et al. | β | 2017 | β |
| Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review. | Park JY et al. | β | 2017 | β |
| The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review. | Nugent SM et al. | β | 2017 | β |
| The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada. | Franklyn AM et al. | β | 2017 | β |
| Toward a Patient Registry for Cannabis Use: An Exploratory Study of Patient Use in an Outpatient Health-Care Clinic in Oregon. | Hoffman KA et al. | β | 2017 | β |
| US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013. | Hasin DS et al. | β | 2017 | β |
| Cannabis befeuert SΓΌchte, aber keine Depressionen. | Mut | β | 2016 | β |
| Marijuana use and service utilization among adolescents 7 years post substance use treatment. | Campbell CI et al. | β | 2016 | β |
| Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys. | Compton WM et al. | β | 2016 | β |
| National Estimates of Marijuana Use and Related Indicators - National Survey on Drug Use and Health, United States, 2002-2014. | Azofeifa A et al. | β | 2016 | β |
| Older-adult marijuana users and ex-users: Comparisons of sociodemographic characteristics and mental and substance use disorders. | Choi NG et al. | β | 2016 | β |
| Older marijuana users: Life stressors and perceived social support. | Choi NG et al. | β | 2016 | β |
| The Epidemiology of DSM-5 Cannabis Use Disorders Among U.S. Adults: Science to Inform Clinicians Working in a Shifting Social Landscape. | Compton WM et al. | β | 2016 | β |
| The natural history of substance use disorders. | Sarvet AL et al. | β | 2016 | β |
| Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. | Murray RM et al. | β | 2016 | β |
| WHY NOT POT?: A Review of the Brain-based Risks of Cannabis. | MacDonald K et al. | β | 2016 | β |